Real-world effectiveness and safety of ranibizumab for the treatment of myopic choroidal neovascularization: Results from the LUMINOUS study

PURPOSE: To assess the 1-year effectiveness, safety, and treatment patterns of ranibizumab in patients with myopic choroidal neovascularization (mCNV) enrolled in the LUMINOUS study. METHODS: This 5-year, prospective, multicenter, observational, study enrolled 30,138 patients across all approved ran...

Descripción completa

Detalles Bibliográficos
Autores principales: Hamilton, Robin D., Clemens, Andreas, Minnella, Angelo Maria, Lai, Timothy Y. Y., Dai, Hong, Sakamoto, Taiji, Gemmy Cheung, Chui Ming, Ngah, Nor Fariza, Dunger-Baldauf, Cornelia, Holz, Frank G.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2020
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6974143/
https://www.ncbi.nlm.nih.gov/pubmed/31961888
http://dx.doi.org/10.1371/journal.pone.0227557

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6974143/
https://www.ncbi.nlm.nih.gov/pubmed/31961888
http://dx.doi.org/10.1371/journal.pone.0227557

Ejemplares similares